Advancements in technology, such as digital pathology and AI-driven diagnostics, have the potential to improve cost effectiveness by enhancing diagnostic accuracy and reducing the time required for analysis. However, the initial investment and training required for new technologies can be high. A thorough cost-benefit analysis is essential to determine the long-term advantages.
